Impact of tumor repopulation on radiotherapy planning

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 1, 2005, Pages 220-227

  Wang, Jian Z ^a,b,d   Li, X Allen ^b,c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Cell repopulation; Dose escalation; Linear quadratic model; Prostate cancer; Radiotherapy

Indexed keywords

CLONOGENS; DOSE PRESCRIPTIONS; PROSTATE CANCER; TUMOR REPOPULATION;

CELLS; IMAGING TECHNIQUES; MATHEMATICAL MODELS; PARAMETER ESTIMATION; POSITRON EMISSION TOMOGRAPHY; PROBABILITY; RADIOTHERAPY;

TUMORS;

IODINE 125;

ARTICLE; BEAM THERAPY; CALCULATION; CANCER CONTROL; CANCER RADIOTHERAPY; CELL KILLING; CELL POPULATION; DOSIMETRY; LINEAR SYSTEM; LOW ENERGY RADIATION; MODEL; POISSON DISTRIBUTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIOBIOLOGY; TREATMENT PLANNING;

BRACHYTHERAPY; CELL PROLIFERATION; HUMANS; LINEAR MODELS; MALE; MODELS, BIOLOGICAL; POISSON DISTRIBUTION; PROSTATIC NEOPLASMS; RADIOBIOLOGY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 11144350193     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.09.043     Document Type: Article

References (40)

1. K. Kubota From tumor biology to clinical PET: A review of positron emission tomography (PET) in oncology Ann Nucl Med 15 2001 471 485
2. S.S. Gambhir Molecular imaging of cancer with positron emission tomography Nat Rev Cancer 2 2002 683 693
3. C. Van de Wiele, C. Lahorte, W. Oyen Nuclear medicine imaging to predict response to radiotherapy: A review Int J Radiat Oncol Biol Phys 55 2003 5 15
4. A. Brahme Biologically optimized 3-dimensional in vivo predictive assay-based radiation therapy using positron emission tomography-computerized tomography imaging Acta Oncol 42 2003 123 136
5. H.R. Withers, J.M. Taylor, B. Maciejewski The hazard of accelerated tumor clonogen repopulation during radiotherapy Acta Oncol 27 1988 131 146
6. R. Tarnawski, J. Fowler, K. Skladowski How fast is repopulation of tumor cell during the treatment gaps? Int J Radiat Oncol Biol Phys 54 2002 229 236
7. M. Baumann, M. Saunders, M.C. Joiner Modified fractionation G.G. Steel Basic clinical radiobiology 2002 Arnold London 147 157
8. J.F. Fowler The linear-quadratic formula and progress in fractionated radiotherapy Br J Radiol 62 1989 679 694
9. J.F. Fowler The effect of overall treatment time in radiotherapy for localized prostate carcinoma [Editorial] Int J Radiat Oncol Biol Phys 21 1991 1087 1098
10. J.F. Fowler Rapid repopulation in radiotherapy: A debate on mechanism Radiother Oncol 22 1991 156 158
11. K.M.G. Haustermans, I. Hofland, H.V. Poppel Cell kinetic measurements in prostate cancer Int J Radiat Oncol Biol Phys 37 1997 1067 1070
12. K. Haustermans, J.F. Fowler A comment on proliferation rates in human prostate cancer [Letter] Int J Radiat Oncol Biol Phys 48 2000 303
13. R.J. Amdur, J.T. Parsons, T.F. Lawrence The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapy Int J Radiat Oncol Biol Phys 19 1990 1377 1382
14. P.P. Lai, C.A. Perez, S.J. Shapiro Carcinoma of the prostate stage B and C: Lack of influence of duration of radiotherapy on tumor control and treatment morbidity Int J Radiat Oncol Biol Phys 19 1990 561 568
15. P.P. Lai, M.V. Pilepicj, J.M. Krall The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: The Radiation Therapy Oncology Group 75-06 and 77-06 experience Int J Radiat Oncol Biol Phys 21 1991 925 933
16. R.G. Dale Radiobiological assessment of permanent implants using tumor repopulation factors in linear-quadratic model Br J Radiol 62 1989 241-224
17. D.J. Brenner, E.J. Hall Fractionation and protraction for radiotherapy of prostate carcinoma Int J Radiat Oncol Biol Phys 43 1999 1095 1101
18. D.J. Brenner, A.A. Martinez, G.K. Edmundson Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue Int J Radiat Oncol Biol Phys 52 2002 6 13
19. J. Fowler, R. Chappell, M. Ritter Is α/β for prostate cancer really low? Int J Radiat Oncol Biol Phys 50 2001 1021 1031
20. J.Z. Wang, M. Guerrero, X.A. Li How low is the α/β ratio for prostate cancer? Int J Radiat Oncol Biol Phys 55 2003 194 203
21. J.Z. Wang, X.A. Li, C.X. Yu The low α/β ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us? Int J Radiat Oncol Biol Phys 57 2003 1101 1108
22. A.E. Nahum, B. Movsas, E.M. Horwitz Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the α/β ratio Int J Radiat Oncol Biol Phys 57 2003 391 401
23. M. Carlone, D. Wilkins, N. Balazs Comparison of α/β estimates from homogeneous (individual) and heterogeneous (population) tumor control models for early stage prostate cancer Med Phys 30 2003 2382 2848
24. H.B. Kal, M.P.R. Van Gellekom How low is the α/β ratio for prostate cancer? Int J Radiat Oncol Biol Phys 57 2003 1116 1121
25. J.Z. Wang, X.A. Li Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose Med Phys 30 2003 34 40
26. R.G. Dale The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy Br J Radiol 58 1985 515 528
27. H.D. Thames An incomplete-repair model for survival after fractionated and continuous irradiations Int J Radiat Biol 47 1985 319 339
28. S.B. Curtis Lethal and potentially lethal lesions induced by radiation--A unified repair model Radiat Res 106 1986 252 270
29. J.Z. Wang, M. Guerrero, X.A. Li Low α/β ratio for prostate cancer: In response to Dr Fowler et al Int J Radiat Oncol Biol Phys 57 2003 595 596
30. S. Webb, A.E.A. Nahum Model for calculating tumor control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density Phys Med Biol 38 1993 653 666
31. S. Levegrün, A. Jackson, M.J. Zelefsky Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: Pitfalls in deducing radiobiologic parameters for tumors from clinical data Int J Radiat Oncol Biol Phys 51 2001 1064 1080
32. H.D. Thames, S.M. Bentzen, I. Turesson Time-dose factors in radiotherapy: A review of the human data Radiother Oncol 19 1990 219 235
33. D.J. Brenner, E.J. Hall Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy Int J Radiat Oncol Biol Phys 20 1991 181 190
34. A.X. Li, J.Z. Wang, R.D. Stewart Dose escalation in permanent brachytherapy for prostate cancer: Dosimetric and biological considerations Phys Med Biol 48 2003 2753 2765
35. 125I seeds Int J Radiat Oncol Biol Phys 28 1994 971 978
36. C.R. King, T.A. DiPetrillo, D.E. Wazer Optimal radiotherapy for prostate cancer: Predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models Int J Radiat Oncol Biol Phys 46 2000 165 172
37. W.A. Tome, J.F. Fowler Selective boosting of tumor subvolumes Int J Radiat Oncol Biol Phys 48 2000 593 599
38. W.A. Tome, J.F. Fowler On cold spots in tumor subvolumes Med Phys 29 2002 1590 1598
39. W.A. Tome, J.F. Fowler On the inclusion of proliferation in tumour control probability calculations for inhomogeneously irradiated tumours Phys Med Biol 48 2003 N261 N268
40. C.R. King, C.S. Mayo Is the prostate α/β ratio of 1.5 from Brenner and Hall a modeling artifact? Int J Radiat Oncol Biol Phys 47 2000 536 538